NEW YORK (Reuters Health) – Combined with ondansetron and dexamethasone, a single intravenous dose of fosaprepitant is as effective as a standard 3-day oral course of aprepitant for…
NEW YORK (Reuters Health) – Adrenal involvement is rare in cases of renal cell carcinoma, even when the tumor is large or in the upper pole. Therefore, concurrent…
NEW YORK (Reuters Health) – Methylene blue has certain advantages over isosulfan blue in sentinel lymph node procedures, but the risk of a palpable mass at the injection…
NEW YORK (Reuters Health) – Women undergoing emetogenic surgical procedures are less likely to have postoperative nausea and vomiting when treated with ondansetron plus casopitant than with ondansetron…
NEW YORK (Reuters Health) – For women with thyroid cancer treated with radioiodine-131, subsequent pregnancy is safe without adverse outcomes for the offspring. That’s according to a report…
NEW YORK (Reuters Health) – The anti-EGFR antibody cetuximab added to two state-of-the-art regimens for metastatic colorectal cancer produces favorable response rates with manageable toxicity, a German team…
NEW YORK (Reuters Health) – Among patients with myeloma treated with thalidomide, antithrombotic prophylactic therapies with aspirin, warfarin or enoxaparin reduce thromboembolic events to a similar degree, according…
NEW YORK (Reuters Health) – In the workup of patients with early esophageal neoplasia, endoscopic ultrasound is unreliable for identifying submucosal infiltration and lymph node involvement — the…
NEW YORK (Reuters Health) – For women with low-risk gestational trophoblastic neoplasia, dactinomycin given every 2 weeks had a higher complete response rate than weekly methotrexate in a…
NEW YORK (Reuters Health) – Compared to conventional white light bronchoscopy, autofluorescence bronchoscopy is more sensitive in detecting lung cancer and preneoplastic lesions, according to a meta-analysis conducted…